Feed HROW
HR
Harrow Health, Inc.
HROW · NASDAQ
$43.71 -0.66% (-$0.29)
1M +10.00%
Market Cap $1.6B
P/E Ratio -
Div. Yield -
ROE 33.79%
Bulios Fair Price
$135.95
211.0% upside
Aktuální cena
$43.71
Podhodnoceno Férová hodnota Nadhodnoceno
Valuation
2 /100
Expensive EV/EBITDA 86.91x
P/S 6.06x
P/B 57.47x
Growth
100 /100
Growing Rev. growth 45.39%
Book val. growth 23.87%
EPS growth N/A
Profitability
43 /100
Moderate Gross margin 74.11%
Net margin 0.00%
Op. margin 7.32%
Quality
7 /100
Poor ROIC 4.77%
ROE 0.00%
ROA 0.00%
Debt
18 /100
High Debt/Equity 10.61x
Current ratio 2.48x
Int. coverage 2.66x
Stability
23 /100
Unstable Beta 0.26x
Rev. volatility 8.54%
EPS volatility 60.65%
Zeptejte se StockBota na HROW
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mark L. Baum
Employees
373
Headquarters
Nashville
Nadcházející události
10 SRP
Earnings
Upcoming earnings report